In a rat neuronal cell line, EGCG significantly increased the levels of Nrf2, a regulator of cellular resistance to oxidants that is reduced in the hippocampus of AD patients [29], and enhances HO-1 expression, which regulates cell adaptation to oxidative stress protecting against cell death [30]. The gene discussed is NFE2L2; the disease is Alzheimer disease.